Scott Turner

932 total citations
10 papers, 667 citations indexed

About

Scott Turner is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Scott Turner has authored 10 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Scott Turner's work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Peptidase Inhibition and Analysis (2 papers). Scott Turner is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Peptidase Inhibition and Analysis (2 papers). Scott Turner collaborates with scholars based in United States, France and Spain. Scott Turner's co-authors include Brian D. Hodgson, Gina Chen, Harry T. Whelan, Helen Stinson, David A. Margolis, Lisa J. Gould, James A. Caviness, Katherine B. Peters, Annick Desjardins and James E. Herndon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Hepatology.

In The Last Decade

Scott Turner

9 papers receiving 621 citations

Peers

Scott Turner
Dong‐In Jung South Korea
Holly B. Hindman United States
Kyung‐Sun Na South Korea
Joel Naor Canada
Scott Turner
Citations per year, relative to Scott Turner Scott Turner (= 1×) peers Martin Reichel

Countries citing papers authored by Scott Turner

Since Specialization
Citations

This map shows the geographic impact of Scott Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Turner more than expected).

Fields of papers citing papers by Scott Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Turner. The network helps show where Scott Turner may publish in the future.

Co-authorship network of co-authors of Scott Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Turner. A scholar is included among the top collaborators of Scott Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Turner. Scott Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ramírez, Ricardo, Abhishek Aggarwal, Nicholas van Buuren, et al.. (2022). Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection. Journal of Hepatology. 77(2). 332–343. 49 indexed citations
2.
Aggarwal, Abhishek, Pamela M. Odorizzi, Jens Brodbeck, et al.. (2022). Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells. JHEP Reports. 5(4). 100664–100664. 17 indexed citations
3.
Buuren, Nicholas van, Ricardo Ramírez, Cameron M. Soulette, et al.. (2022). Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B. JHEP Reports. 4(4). 100449–100449. 37 indexed citations
4.
Stinson, Susanna, Jianhua He, Kyung-Hoon Kim, et al.. (2021). 577 Non-clinical efficacy, pharmacokinetics, and pharmacodynamics of a novel bi-functional anti-CD73-TGFβRII-trap molecule in combination with immune checkpoint therapy. SHILAP Revista de lepidopterología. A606–A606. 1 indexed citations
5.
Shah, Manish A., David Cunningham, Jean‐Philippe Metges, et al.. (2021). Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival. Journal for ImmunoTherapy of Cancer. 9(12). e003580–e003580. 36 indexed citations
6.
Metges, Jean‐Philippe, Emon Elboudwarej, David Cunningham, et al.. (2019). Exploratory evaluation of baseline tumor biomarkers and their association with response and survival in patients with previously treated advanced gastric cancer treated with andecaliximab combined with nivolumab versus nivolumab.. Journal of Clinical Oncology. 37(4_suppl). 148–148. 1 indexed citations
7.
Peters, Katherine B. & Scott Turner. (2013). Acquired stuttering due to recurrent anaplastic astrocytoma. BMJ Case Reports. 2013. bcr2013009562–bcr2013009562. 6 indexed citations
8.
Lou, Emil, Ashley Sumrall, Scott Turner, et al.. (2012). Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series. Journal of Neuro-Oncology. 109(1). 63–70. 144 indexed citations
9.
Sumrall, Ashley, David A. Reardon, Annick Desjardins, et al.. (2011). Venous thromboembolic complications in patients with malignant glioma treated on a bevacizumab clinical trial.. Journal of Clinical Oncology. 29(15_suppl). 9090–9090.
10.
Whelan, Harry T., Scott Turner, David A. Margolis, et al.. (2001). Effect of NASA Light-Emitting Diode Irradiation on Wound Healing. Journal of Clinical Laser Medicine & Surgery. 19(6). 305–314. 376 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026